Sirnaomics’ siRNA Therapeutic To Begin Clinical Trials In China
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - Sirnaomics' RNAi therapeutic STP601 will begin clinical trials in China in late 2008, Patrick Lu, founder, president and CEO of Sirnaomics, told PharmAsia News